Why Costco Stock Was Moving Higher Today

What happened

Shares of Costco Wholesale (NASDAQ:COST) were rising today after the warehouse retailer turned in a strong second-quarter earnings report with better-than-expected profits. As a result, the stock was up 5.4% as of 10:56 a.m. EST.

So what  

Costco continued to demonstrate why it's a best-in-class retailer, posting comparable-store sales growth of 6.7%, excluding fuel, and 7.2% in the U.S. E-commerce sales, a key focus for the company these days, were up 25.5%, and overall revenue increased 7.3% to $35.4 billion, though that was slightly below analyst expectations at $35.67 billion. 

The parking lot outside of a Costco store

Image source: Costco.

Gross margin climbed from 11% to 11.3%, leading to operating income jumping 18.4% to $1.2 billion. That drove earnings per share up from $1.59 to $2.01, which easily beat estimates at $1.69. 

Costco announced a wage increase earlier in the week, lifting starting hourly wages from a range of $14 to $14.50 to a range of $15 to $15.50 in the U.S. and Canada; wages for supervisors also went up. On the earnings call, CFO Richard Galanti noted a broader online selection of products including new iMacs and MacBooks, and well as expansions in supply and processing plants for meat and chicken, and a new bakery in Canada. 

Now what

Costco does not provide quarterly guidance, but the company updated its adjusted comps figures for the first four weeks of the third quarter, saying they were up 4.6% overall and 5.7% in the U.S. It said February growth was hurt by bad weather in North America and a shift earlier in the Lunar New Year. E-commerce sales increased 21.6% in that period.

While that may indicate slower growth in the third quarter, Costco continues to successfully adapt to the changing retail environment by embracing e-commerce, and is adding new stores, with three expected in the current quarter. Given the strong profit growth, it's not surprising to see the stock climbing today.

Roper Technologies (ROP) & Clearsign Combustion (CLIR) Head-To-Head Contrast

Roper Technologies (NYSE:ROP) and Clearsign Combustion (NASDAQ:CLIR) are both industrial products companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, dividends, earnings, analyst recommendations, profitability, institutional ownership and risk.

Profitability

Get Roper Technologies alerts:

This table compares Roper Technologies and Clearsign Combustion’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Roper Technologies 18.19% 16.57% 8.23%
Clearsign Combustion N/A -69.38% -61.26%

Insider and Institutional Ownership

91.0% of Roper Technologies shares are held by institutional investors. Comparatively, 14.9% of Clearsign Combustion shares are held by institutional investors. 2.3% of Roper Technologies shares are held by insiders. Comparatively, 5.7% of Clearsign Combustion shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Analyst Ratings

This is a summary of recent ratings and price targets for Roper Technologies and Clearsign Combustion, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Roper Technologies 0 3 5 0 2.63
Clearsign Combustion 0 0 0 0 N/A

Roper Technologies presently has a consensus target price of $319.43, suggesting a potential downside of 0.12%. Given Roper Technologies’ higher probable upside, research analysts clearly believe Roper Technologies is more favorable than Clearsign Combustion.

Dividends

Roper Technologies pays an annual dividend of $1.85 per share and has a dividend yield of 0.6%. Clearsign Combustion does not pay a dividend. Roper Technologies pays out 15.7% of its earnings in the form of a dividend. Roper Technologies has increased its dividend for 20 consecutive years.

Valuation and Earnings

This table compares Roper Technologies and Clearsign Combustion’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Roper Technologies $5.19 billion 6.37 $944.40 million $11.81 27.08
Clearsign Combustion $530,000.00 47.79 -$9.68 million N/A N/A

Roper Technologies has higher revenue and earnings than Clearsign Combustion.

Risk and Volatility

Roper Technologies has a beta of 1.13, indicating that its share price is 13% more volatile than the S&P 500. Comparatively, Clearsign Combustion has a beta of 0.51, indicating that its share price is 49% less volatile than the S&P 500.

Summary

Roper Technologies beats Clearsign Combustion on 11 of the 14 factors compared between the two stocks.

Roper Technologies Company Profile

Roper Technologies, Inc. designs and develops software, and engineered products and solutions. It operates in four segments: RF Technology; Medical & Scientific Imaging; Industrial Technology; and Energy Systems & Controls. The company offers radio frequency identification (RFID) communication technology and software solutions, including application management software, software-as-a-service applications, card systems/integrated security solutions, toll and traffic systems, RFID card readers, and metering and remote monitoring products. It also offers diagnostic and laboratory software solutions; patient positioning devices and related software, 3-D measurement technology, and diagnostic and therapeutic disposable products; non-invasive instruments and video laryngoscopes; and a cloud-based financial analytics and performance software platform, as well as electron filters, charged couple devices, and complementary metal oxide semiconductor cameras, detectors, and related software. In addition, the company offers water meter and automatic meter reading products and systems, fluid handling pumps, materials analysis equipment and consumables, flow measurement and metering equipment, industrial valves and controls, and industrial leak testing products. Further, it provides control systems, fluid properties testing equipment, valves, vibration sensors and controls, and non-destructive inspection and measurement products and solutions. Additionally, the company provides enterprise software and information solutions for government contractors, professional services firms, and other project-based businesses. It serves healthcare, food, energy, water, education, and construction industries, as well as law and professional services firms in the United States and internationally. The company was formerly known as Roper Industries, Inc. and changed its name to Roper Technologies, Inc. in April 2015. Roper Technologies, Inc. was founded in 1981 and is based in Sarasota, Florida.

Clearsign Combustion Company Profile

ClearSign Combustion Corporation designs and develops technologies to enhance emission and operational performance, energy efficiency, and overall cost-effectiveness of combustion systems in the United States. Its Duplex, Duplex Plug & Play, and Electrodynamic Combustion Control platform technologies enhance the performance of combustion systems in a range of markets, including energy, commercial/industrial boiler, chemical, petrochemical, and power industries. ClearSign Combustion Corporation was founded in 2008 and is headquartered in Seattle, Washington.

D-Street Buzz: Nifty PSU Bank outperforms led by PNB; Wipro sheds 2%, RIL most active

The Indian benchmark indices continues to trade flat this Thursday afternoon with Nifty down 17 points, trading at 11036 while the Sensex shed 10 points and was trading at 36,626 mark.

Nifty Metal was down close to a percent dragged by SAIL, Tata Steel, Jindal Stainless, MOIL, Coal India, NALCO, Hindalco Industries and Hindustan Copper.

Media stocks also remained weak led by DEN Networks which shed 3 percent followed by Zee Entertainment, Hathway Cable, Network18, Sun TV, Jagran Prakashan and TV Today.

From the pharma space, the top losers were Divis Labs, Sun Pharma, Cadila Healthcare and Cipla.

related news SJVN climbs 13% after Cabinet nod to investment in Buxar Thermal Power Project NHPC rallies 8% after Cabinet nod to investment in Chenab valley, acquisition of Lanco Teesta hydro project

However, Nifty PSU Bank was up close to a percent led by Punjab National Bank, Bank of Baroda, Bank of India, Oriental Bank, Union Bank and Vijaya Bank.

The top gainers from NSE included Larsen & Toubro, Mahindra & Mahindra, HPCL, Bharti Infratel and Tata Motors while the top losers included Indiabulls Housing Finance, Wipro, Vedanta, Indian Oil Corporation and YES Bank.

The most active stocks were Reliance Industries, L&T, M&M, Tata Motors and YES Bank.

19 stocks have hit new 52-week high on NSE including Bata India, Praj Industries, REC, Dalmia Bharat Sugar, Aavas Financiers and Adani Gas.

The breadth of the market favoured the declines with 821 stocks advancing and 891 declining while 357 remained unchanged. On the BSE, 1184 stocks advanced, 1206 declined and 162 remained unchanged.

Disclosure: Reliance Industries Ltd. is the sole beneficiary of Independent Media Trust which controls Network18 Media & Investments Ltd.

For more market news, click here First Published on Mar 7, 2019 01:03 pm

Why Barnes & Noble Education Stock Plunged 32% Today

What happened

Barnes & Noble Education (NYSE:BNED) closed the book on its fiscal Q3 2019 today, reporting a slight GAAP profit but a worsening decline in sales. Investors sold off the stock in response -- down 32% by close of trading, roughly equaling the sell-off we saw the last time the company reported earnings, for Q2 2019.

So what

Expected to earn $0.11 per share on $591.1 million in sales in Q3, the college bookstore operator instead reported a bare $0.02 per share earned on sales of just $550.3 million. Sales declined 9% year over year, while profits -- if not all that Wall Street had hoped they would be -- were at least positive, versus the company's $6.04 per-share GAAP loss reported one year ago.

Barnes & Noble Education blamed "the acceleration from physical textbooks to digital offerings" for what management called "somewhat higher than expected declines in revenue and EBITDA." Still, management insisted "we are confident in our ability to manage these businesses for margin and cash flow while we invest in and begin to scale high value digital growth platforms and offerings."

Row of brightly colored textbooks

Image source: Getty Images.

Now what

Investors appear to be less confident. And it probably didn't help that, after reporting its big miss on both sales and earnings, Barnes & Noble Education proceeded to warn that it expects full-year sales to be only between $2.15 billion and $2.2 billion this year -- down from a previous projection of $2.2 billion to $2.3 billion.

Wall Street, by the way, thinks the best the company will be able to manage is $2.1 billion -- and based on how investors are reacting today, I'd say they agree with the analysts on this one.

Ionis Pharmaceuticals (IONS) Hits New 12-Month High at $72.41

Shares of Ionis Pharmaceuticals Inc (NASDAQ:IONS) reached a new 52-week high on Tuesday . The stock traded as high as $72.41 and last traded at $72.37, with a volume of 551342 shares traded. The stock had previously closed at $70.49.

Several analysts have recently weighed in on the company. Piper Jaffray Companies lifted their target price on Ionis Pharmaceuticals to $60.00 and gave the stock a “neutral” rating in a research report on Thursday, February 28th. ValuEngine upgraded Ionis Pharmaceuticals from a “buy” rating to a “strong-buy” rating in a report on Thursday, February 28th. BMO Capital Markets lifted their price objective on Ionis Pharmaceuticals from $70.00 to $82.00 and gave the company an “outperform” rating in a report on Thursday, February 28th. TheStreet upgraded Ionis Pharmaceuticals from a “c” rating to a “b-” rating in a report on Friday. Finally, Morgan Stanley set a $71.00 price objective on Ionis Pharmaceuticals and gave the company a “hold” rating in a report on Friday. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating, two have issued a buy rating and one has issued a strong buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average target price of $60.57.

Get Ionis Pharmaceuticals alerts:

The company has a debt-to-equity ratio of 0.74, a current ratio of 7.99 and a quick ratio of 7.96. The firm has a market cap of $8.08 billion, a price-to-earnings ratio of 24.06 and a beta of 2.28.

Ionis Pharmaceuticals (NASDAQ:IONS) last posted its earnings results on Wednesday, February 27th. The company reported $2.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.01 by $2.20. Ionis Pharmaceuticals had a negative return on equity of 1.58% and a negative net margin of 7.52%. The company had revenue of $192.00 million for the quarter, compared to analyst estimates of $159.59 million. During the same quarter in the previous year, the firm earned ($0.03) earnings per share. The firm’s quarterly revenue was up 14.3% compared to the same quarter last year. As a group, equities analysts forecast that Ionis Pharmaceuticals Inc will post -0.18 EPS for the current fiscal year.

In other Ionis Pharmaceuticals news, SVP Elizabeth L. Hougen sold 4,063 shares of Ionis Pharmaceuticals stock in a transaction dated Wednesday, December 19th. The stock was sold at an average price of $52.03, for a total value of $211,397.89. Following the transaction, the senior vice president now owns 16,774 shares in the company, valued at $872,751.22. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director B Lynne Parshall sold 8,333 shares of Ionis Pharmaceuticals stock in a transaction dated Wednesday, February 27th. The shares were sold at an average price of $70.00, for a total value of $583,310.00. Following the completion of the transaction, the director now owns 61,010 shares in the company, valued at approximately $4,270,700. The disclosure for this sale can be found here. Insiders sold 197,326 shares of company stock worth $12,114,304 in the last quarter. 2.44% of the stock is owned by insiders.

Institutional investors and hedge funds have recently bought and sold shares of the business. Norges Bank purchased a new stake in Ionis Pharmaceuticals in the fourth quarter valued at approximately $54,463,000. Dimensional Fund Advisors LP boosted its position in Ionis Pharmaceuticals by 9.0% in the fourth quarter. Dimensional Fund Advisors LP now owns 292,868 shares of the company’s stock valued at $15,827,000 after buying an additional 24,169 shares during the last quarter. Amalgamated Bank boosted its position in Ionis Pharmaceuticals by 62.9% in the fourth quarter. Amalgamated Bank now owns 27,879 shares of the company’s stock valued at $1,507,000 after buying an additional 10,762 shares during the last quarter. Macquarie Group Ltd. boosted its position in Ionis Pharmaceuticals by 2.7% in the fourth quarter. Macquarie Group Ltd. now owns 23,989 shares of the company’s stock valued at $1,297,000 after buying an additional 623 shares during the last quarter. Finally, AE Wealth Management LLC acquired a new position in Ionis Pharmaceuticals in the fourth quarter valued at approximately $313,000. Institutional investors own 84.55% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Ionis Pharmaceuticals (IONS) Hits New 12-Month High at $72.41” was published by Ticker Report and is the sole property of of Ticker Report. If you are accessing this piece of content on another publication, it was stolen and reposted in violation of United States and international trademark & copyright laws. The correct version of this piece of content can be read at https://www.tickerreport.com/banking-finance/4199448/ionis-pharmaceuticals-ions-hits-new-12-month-high-at-72-41.html.

About Ionis Pharmaceuticals (NASDAQ:IONS)

Ionis Pharmaceuticals, Inc discovers and develops RNA-targeted therapeutics. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; and Kynamro an oligonucleotide inhibitor for use in patients with homozygous familial hypercholesterolemia to reduce low density lipoprotein-cholesterol, apolipoprotein B, total cholesterol, and non-high density lipoprotein.

Read More: What is a Backdoor Roth IRA?

3 Coiled Blue-Chip Tech Stocks Ready to Spring Higher

Despite falling after the open, stocks could very well continue higher this week, and I’m finding many attractive setups in the technology sector. Indeed, some blue-chip tech stocks have been coiling and now appear ready to pop. Today, we’ll breakdown three candidates that are top picks for buyers.

Last week’s test of overhead resistance for the broad market was telling. Ever since the early-October beatdown in the S&P 500, the 2800 level has acted as an impenetrable ceiling halting multiple recovery attempts. But last week’s test appears altogether different. Rather than a vicious rejection, prices are absorbing overhead supply like a champ. Sellers have proven powerless to reverse this year’s rally.

And that has me thinking a breakout is inevitable. While some blue-chip stocks remain extended, others entered pausing patterns weeks ago and are thus providing clear low-risk entries.

Here are three of the best.


Compare Brokers
3 Large Cap Tech Stocks Springing Higher: Apple (AAPL)
Click to Enlarge Source: ThinkorSwim

Apple (NASDAQ:AAPL) tops our list with a gorgeous consolidation pattern. Ever since the post-earnings pole vault that propelled the tech titan back into an uptrend, selling pressure has been virtually nonexistent. The multi-week pause settling on the stock has created a shallow cup-and-handle pattern that is now on the cusp of completion.

The next resistance zone isn’t until $185 to $191, so AAPL stock has plenty of room to run as well. Additionally, the rising 20-day and now 50-day moving average officially confirm buyers have wrested back control of the short-term and intermediate-term trends.

Buy the May $175/$185 bull call spread for $4.50. The risk is $4.50 and will be lost if AAPL sits below $175 at expiration. The max reward of $5.50 will be captured if the stock can climb above $185 by expiration.


Compare Brokers
3 Large Cap Tech Stocks Springing Higher: Amazon (AMZN)
Click to Enlarge Source: ThinkorSwim

Amazon (NASDAQ:AMZN) shares have been uncharacteristically quiet for the past two months. But if Friday’s action is any indication, the online retail giant is awakening from its slumber. Volatility for stock prices tends to alternate between periods of expansion and contraction. This is where the coiled spring reference comes in.

I view the narrow consolidation as a coiled spring that carries pent-up energy that will soon be released once AMZN stock finally figures out which way it wants to break out. Given the healthy market backdrop and strength of the technology sector, I think we can all agree the likely direction of the break is higher.

Friday’s high volume pop is providing confirmation.

To bank on more upside, consider buying bull call spreads which offer defined risk bet. Buy the May $1700/$1750 bull call spread for $23.80. The risk is capped at $23.80, and the potential reward is $26.20.


Compare Brokers
3 Large Cap Tech Stocks Springing Higher: Alphabet (GOOGL)
Click to Enlarge Source: ThinkorSwim

Alphabet (NASDAQ:GOOGL) rounds out today’s selections with a chart just begging to break out. Some would say Friday’s rally already confirmed it.

Though choppy, the action in Alphabet stock over the past five months has created a rounded bottom. The transition from lower swing lows to higher swing lows reveals the shift in control from sellers to buyers.

As the right side of the bottom has formed, distribution days have disappeared, and moving averages have reversed higher. Friday’s pop vaulted GOOGL stock above its 200-day moving average and completed a mini-symmetrical triangle pattern.

If you think the recovery continues, then buy the May $1160/$1180 bull call spread for $10. The risk and reward are both $10.

As of this writing, Tyler Craig held bullish positions in AMZN. Check out his recently released Bear Market Survival Guide to learn how to defend your portfolio against

Apollo Global Management LLC (APO) Files 10-K for the Fiscal Year Ended on December 31, 2018

Apollo Global Management LLC (NYSE:APO) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. Apollo Global Management LLC is an alternative-asset management company. It invests and manages funds on behalf of prominent pension, endowment and sovereign wealth funds as well as other institutional and individual investors. Apollo Global Management LLC has a market cap of $11.96 billion; its shares were traded at around $29.24 with and P/S ratio of 2.83. The dividend yield of Apollo Global Management LLC stocks is 6.25%.

For the last quarter Apollo Global Management LLC reported a revenue of $-114.89 million, compared with the revenue of $869.5 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $1.1 billion, a decrease of 58.1% from the previous year. For the last five years Apollo Global Management LLC had an average revenue decline of 10.7% a year.

The reported loss per diluted share was 10.3 cents for the year, compared with the earnings per share of $2.11 in the previous year. The Apollo Global Management LLC had an operating margin of 5.77%, compared with the operating margin of 49.92% a year before. The 10-year historical median operating margin of Apollo Global Management LLC is 32.12%. The profitability rank of the company is 5 (out of 10).

At the end of the fiscal year, Apollo Global Management LLC has the cash and cash equivalents of $659.4 million, compared with $844.2 million in the previous year. The long term debt was $2.2 billion, compared with $2.4 billion in the previous year. The interest coverage to the debt is 1.1, which is not a favorable level. Apollo Global Management LLC has a financial strength rank of 5 (out of 10).

At the current stock price of $29.24, Apollo Global Management LLC is traded at 21.5% premium to its historical median P/S valuation band of $24.07. The P/S ratio of the stock is 2.83, while the historical median P/S ratio is 2.32. The stock lost 5.09% during the past 12 months.

CFO Recent Trades:

CFO Martin Kelly sold 9,800 shares of APO stock on 02/11/2019 at the average price of $29.66. The price of the stock has decreased by 1.42% since.

For the complete 20-year historical financial data of APO, click here.